ID HMOX1_BOVIN Reviewed; 289 AA. AC Q5E9F2; Q3ZCK7; Q7M338; DT 30-AUG-2005, integrated into UniProtKB/Swiss-Prot. DT 15-MAR-2005, sequence version 1. DT 27-MAR-2024, entry version 119. DE RecName: Full=Heme oxygenase 1; DE Short=HO-1; DE EC=1.14.14.18 {ECO:0000269|PubMed:6806282}; DE Contains: DE RecName: Full=Heme oxygenase 1 soluble form {ECO:0000250|UniProtKB:P09601}; GN Name=HMOX1; OS Bos taurus (Bovine). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; OC Bovinae; Bos. OX NCBI_TaxID=9913; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RX PubMed=16305752; DOI=10.1186/1471-2164-6-166; RA Harhay G.P., Sonstegard T.S., Keele J.W., Heaton M.P., Clawson M.L., RA Snelling W.M., Wiedmann R.T., Van Tassell C.P., Smith T.P.L.; RT "Characterization of 954 bovine full-CDS cDNA sequences."; RL BMC Genomics 6:166-166(2005). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=Crossbred X Angus; TISSUE=Ileum; RG NIH - Mammalian Gene Collection (MGC) project; RL Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases. RN [3] RP PROTEIN SEQUENCE OF 24-33; 41-49; 88-113; 138-147; 155-158; 187-196 AND RP 200-205. RC TISSUE=Spleen; RX PubMed=1700666; DOI=10.1016/0003-9861(90)90136-m; RA Schacter B.A., Cripps V., Troxler R.F., Offner G.D.; RT "Structural studies on bovine spleen heme oxygenase. Immunological and RT structural diversity among mammalian heme oxygenase enzymes."; RL Arch. Biochem. Biophys. 282:404-412(1990). RN [4] RP FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND ACTIVITY RP REGULATION. RX PubMed=6806282; DOI=10.1016/s0021-9258(18)34449-1; RA Yoshinaga T., Sassa S., Kappas A.; RT "Purification and properties of bovine spleen heme oxygenase. Amino acid RT composition and sites of action of inhibitors of heme oxidation."; RL J. Biol. Chem. 257:7778-7785(1982). CC -!- FUNCTION: [Heme oxygenase 1]: Catalyzes the oxidative cleavage of heme CC at the alpha-methene bridge carbon, released as carbon monoxide (CO), CC to generate biliverdin IXalpha, while releasing the central heme iron CC chelate as ferrous iron (PubMed:6806282). Affords protection against CC programmed cell death and this cytoprotective effect relies on its CC ability to catabolize free heme and prevent it from sensitizing cells CC to undergo apoptosis (By similarity). {ECO:0000250|UniProtKB:P09601, CC ECO:0000269|PubMed:6806282}. CC -!- FUNCTION: [Heme oxygenase 1 soluble form]: Catalyzes the oxidative CC cleavage of heme at the alpha-methene bridge carbon, released as carbon CC monoxide (CO), to generate biliverdin IXalpha, while releasing the CC central heme iron chelate as ferrous iron. CC {ECO:0000250|UniProtKB:P09601}. CC -!- CATALYTIC ACTIVITY: CC Reaction=heme b + 3 O2 + 3 reduced [NADPH--hemoprotein reductase] = CC biliverdin IXalpha + CO + Fe(2+) + H(+) + 3 H2O + 3 oxidized CC [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:21764, Rhea:RHEA- CC COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:17245, CC ChEBI:CHEBI:29033, ChEBI:CHEBI:57618, ChEBI:CHEBI:57991, CC ChEBI:CHEBI:58210, ChEBI:CHEBI:60344; EC=1.14.14.18; CC Evidence={ECO:0000269|PubMed:6806282}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:21765; CC Evidence={ECO:0000305|PubMed:6806282}; CC -!- ACTIVITY REGULATION: Inhibited by metalloporphyrins such as Sn-, Co-, CC Mn- and Zn-protoporphyrins. {ECO:0000269|PubMed:6806282}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=0.93 uM for heme b {ECO:0000269|PubMed:6806282}; CC -!- SUBUNIT: Homodimer and higher order homooligomer. Oligomerization is CC crucial for its stability and function in the endoplasmic reticulum. CC Interacts with FLVCR2; this interaction is potentiated in the presence CC of heme. {ECO:0000250|UniProtKB:P14901}. CC -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane CC {ECO:0000250|UniProtKB:P09601}; Single-pass type IV membrane protein CC {ECO:0000255}; Cytoplasmic side {ECO:0000250|UniProtKB:P09601}. CC -!- DOMAIN: The transmembrane domain is necessary for its oligomerization. CC {ECO:0000250|UniProtKB:P09601}. CC -!- PTM: A soluble form arises by proteolytic removal of the membrane CC anchor. {ECO:0000250|UniProtKB:P09601}. CC -!- SIMILARITY: Belongs to the heme oxygenase family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; BT020968; AAX08985.1; -; mRNA. DR EMBL; BC102105; AAI02106.4; -; mRNA. DR PIR; S13265; S13265. DR RefSeq; NP_001014912.1; NM_001014912.1. DR AlphaFoldDB; Q5E9F2; -. DR SMR; Q5E9F2; -. DR STRING; 9913.ENSBTAP00000061215; -. DR ChEMBL; CHEMBL1255146; -. DR PaxDb; 9913-ENSBTAP00000020701; -. DR Ensembl; ENSBTAT00000020701.6; ENSBTAP00000020701.5; ENSBTAG00000015582.6. DR GeneID; 513221; -. DR KEGG; bta:513221; -. DR CTD; 3162; -. DR VEuPathDB; HostDB:ENSBTAG00000015582; -. DR VGNC; VGNC:29885; HMOX1. DR eggNOG; KOG4480; Eukaryota. DR GeneTree; ENSGT00390000017673; -. DR HOGENOM; CLU_057050_0_1_1; -. DR InParanoid; Q5E9F2; -. DR OrthoDB; 1366343at2759; -. DR TreeFam; TF314786; -. DR BRENDA; 1.14.14.18; 908. DR Reactome; R-BTA-189483; Heme degradation. DR Reactome; R-BTA-917937; Iron uptake and transport. DR Reactome; R-BTA-9609523; Insertion of tail-anchored proteins into the endoplasmic reticulum membrane. DR Reactome; R-BTA-9707564; Cytoprotection by HMOX1. DR Reactome; R-BTA-9707587; Regulation of HMOX1 expression and activity. DR SABIO-RK; Q5E9F2; -. DR Proteomes; UP000009136; Chromosome 5. DR ExpressionAtlas; Q5E9F2; baseline and differential. DR GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB. DR GO; GO:0005634; C:nucleus; IEA:Ensembl. DR GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl. DR GO; GO:0020037; F:heme binding; IBA:GO_Central. DR GO; GO:0004392; F:heme oxygenase (decyclizing) activity; IDA:UniProtKB. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl. DR GO; GO:0005198; F:structural molecule activity; IEA:Ensembl. DR GO; GO:0071243; P:cellular response to arsenic-containing substance; IEA:Ensembl. DR GO; GO:0071276; P:cellular response to cadmium ion; IEA:Ensembl. DR GO; GO:0072719; P:cellular response to cisplatin; IEA:Ensembl. DR GO; GO:0034605; P:cellular response to heat; IEA:Ensembl. DR GO; GO:0071456; P:cellular response to hypoxia; IEA:Ensembl. DR GO; GO:1904019; P:epithelial cell apoptotic process; IEA:Ensembl. DR GO; GO:0034101; P:erythrocyte homeostasis; IEA:Ensembl. DR GO; GO:0042167; P:heme catabolic process; IBA:GO_Central. DR GO; GO:0006788; P:heme oxidation; IBA:GO_Central. DR GO; GO:0006879; P:intracellular iron ion homeostasis; IEA:Ensembl. DR GO; GO:0016236; P:macroautophagy; IEA:Ensembl. DR GO; GO:0060586; P:multicellular organismal-level iron ion homeostasis; IEA:Ensembl. DR GO; GO:0043922; P:negative regulation by host of viral transcription; IMP:AgBase. DR GO; GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl. DR GO; GO:0016242; P:negative regulation of macroautophagy; IEA:Ensembl. DR GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; IEA:Ensembl. DR GO; GO:1903901; P:negative regulation of viral life cycle; IMP:AgBase. DR GO; GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl. DR GO; GO:1903589; P:positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; IEA:Ensembl. DR GO; GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; IEA:Ensembl. DR GO; GO:1904037; P:positive regulation of epithelial cell apoptotic process; IEA:Ensembl. DR GO; GO:0016239; P:positive regulation of macroautophagy; IEA:Ensembl. DR GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl. DR GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IEA:Ensembl. DR GO; GO:0035094; P:response to nicotine; IEA:Ensembl. DR GO; GO:0006979; P:response to oxidative stress; IBA:GO_Central. DR GO; GO:0002246; P:wound healing involved in inflammatory response; IEA:Ensembl. DR CDD; cd00232; HemeO-like; 1. DR Gene3D; 1.20.910.10; Heme oxygenase-like; 1. DR InterPro; IPR002051; Haem_Oase. DR InterPro; IPR016053; Haem_Oase-like. DR InterPro; IPR016084; Haem_Oase-like_multi-hlx. DR InterPro; IPR018207; Haem_oxygenase_CS. DR PANTHER; PTHR10720; HEME OXYGENASE; 1. DR PANTHER; PTHR10720:SF1; HEME OXYGENASE 1; 1. DR Pfam; PF01126; Heme_oxygenase; 1. DR PRINTS; PR00088; HAEMOXYGNASE. DR SUPFAM; SSF48613; Heme oxygenase-like; 1. DR PROSITE; PS00593; HEME_OXYGENASE; 1. PE 1: Evidence at protein level; KW Apoptosis; Direct protein sequencing; Endoplasmic reticulum; Heme; Iron; KW Membrane; Metal-binding; Oxidoreductase; Phosphoprotein; KW Reference proteome; Transmembrane; Transmembrane helix. FT CHAIN 1..289 FT /note="Heme oxygenase 1" FT /id="PRO_0000209686" FT CHAIN 1..266 FT /note="Heme oxygenase 1 soluble form" FT /evidence="ECO:0000250|UniProtKB:P09601" FT /id="PRO_0000455620" FT TOPO_DOM 1..266 FT /note="Cytoplasmic" FT /evidence="ECO:0000250|UniProtKB:P09601" FT TRANSMEM 267..289 FT /note="Helical; Anchor for type IV membrane protein" FT /evidence="ECO:0000255" FT REGION 1..24 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 239..261 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 19 FT /ligand="heme b" FT /ligand_id="ChEBI:CHEBI:60344" FT /evidence="ECO:0000250|UniProtKB:P09601" FT BINDING 26 FT /ligand="heme b" FT /ligand_id="ChEBI:CHEBI:60344" FT /ligand_part="Fe" FT /ligand_part_id="ChEBI:CHEBI:18248" FT /note="axial binding residue" FT /evidence="ECO:0000250|UniProtKB:P09601" FT BINDING 135 FT /ligand="heme b" FT /ligand_id="ChEBI:CHEBI:60344" FT /evidence="ECO:0000250|UniProtKB:P09601" FT BINDING 184 FT /ligand="heme b" FT /ligand_id="ChEBI:CHEBI:60344" FT /evidence="ECO:0000250|UniProtKB:P09601" FT SITE 141 FT /note="Important for catalytic activity" FT /evidence="ECO:0000250|UniProtKB:P09601" FT MOD_RES 243 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P06762" FT CONFLICT 28 FT /note="Q -> E (in Ref. 3; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 100 FT /note="P -> PH (in Ref. 3; AA sequence)" FT /evidence="ECO:0000305" SQ SEQUENCE 289 AA; 32940 MW; 8EAEA06BCCA4B96C CRC64; MERPQPDSSM PQDLSEALKE ATKEVHTQAE NAEFMKNFQK GELTQEGFKL VMASLYHIYV ALEEEIERNK ENPVYTPLYF PEELHRRASL EQDMAFWYGP RWQEAIPYTQ ATKRYVQRLQ EVGRTEPELL VAHAYTRYLG DLSGGQVLKK IAQKALNLPS SGEGLAFFTF PNIASATKFK QLYRSRMNTL EMTPEVRQRV LDEAKTAFLL NIQLFEELQG LLTQKAKDHD PLQAPELHRR AGSKVQDLAP TKASRGKPQP SVLSQAPLLR WVLTLSFLVA TVAVGLYAM //